Papaverine bufus, 20 mg/ml 2 ml 10 pcs

Active ingredient

Papaverine

How to take, the dosage

The drug is administered intramuscularly or intravenously.

Interaction

Papaverine reduces antiparkinsonian effect of levodopa, reduces hypotensive effect of methyldopa. In combination with barbiturates spasmolytic effect of papaverine hydrochloride increases.

Special Instructions

The drug should be administered intravenously slowly and under a physician’s supervision.

Alcohol should be avoided during treatment. The safety of the drug in pregnancy and lactation has not been established.

Contraindications

Comatose state, respiratory depression, violation of atrioventricular conduction; age under 1 year; hypersensitivity to the drug. Glaucoma, severe hepatic insufficiency, advanced age (risk of hyperthermia).

With caution
States after craniocerebral injury, chronic renal failure, insufficiency of adrenal function, hypothyroidism, prostatic hyperplasia, supraventricular tachycardia, shock conditions.

Side effects

Allergic reactions, decreased blood pressure, increased activity of liver transaminases, eosinophilia, drowsiness, headache, nausea, constipation, increased sweating are possible.

Overdose

Symptoms: diplopia, weakness, decreased blood pressure, drowsiness.

Pregnancy use

The safety of the drug in pregnancy and lactation has not been established.